Despite the widespread use of inhalational anaesthetics in modern medical practice it is still unable to create an "ideal" anesthetic, which meets the following requirements--maximum performance, security, and manageability. Desflurane is an inhalational anaesthetic, which first appeared on Russian market in 2013, according to the specifications meet the above-mentioned requirements. The results of the use of Desflurane during anaesthesia in 157 patients of the Cancer Department and Department of Oral and Maxillofacial Surgery at the Burdenko Main Military Clinical Hospital are given.
View Article and Find Full Text PDF